Efficacy and safety of a lower-dose valganciclovir (valcyte) regimen for cytomegalovirus prophylaxis in kidney and pancreas transplant recipients.

Bhat,McIntyre M,Meyers T

Efficacy and safety of a lower-dose valganciclovir (valcyte) regimen for cytomegalovirus prophylaxis in kidney and pancreas transplant recipients.

2010

Bhat
McIntyre M
Meyers T

Purpose: We evaluated the efficacy and safety of the current cytomegalovirus (CMV) prophylaxis regimen used at Virginia Mason Medical Center in Seattle.

Keywords:

Intensive care medicine
Valganciclovir
Regimen
Pancreas
Pathology
Kidney
Medicine
Leukopenia
Pancreas transplantation
Serostatus
Population study
Internal medicine
Transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations